| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/13/2008 | EP1233770B1 Phosphonate compounds |
| 02/13/2008 | EP1140022B1 Method of administering a compound to multi-drug resistant cells |
| 02/13/2008 | EP0755454B1 Aav-mediated delivery of dna to cells of the nervous system |
| 02/13/2008 | CN101124327A Modified CEA/B7 vector |
| 02/13/2008 | CN101124318A Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/13/2008 | CN101124228A Pyrazolopyrimidine compounds as antitumor agents |
| 02/13/2008 | CN101124227A Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 02/13/2008 | CN101124223A Pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof |
| 02/13/2008 | CN101124219A Novel farnesyl protein transferase inhibitors as antitumor agents |
| 02/13/2008 | CN101124211A Antibiotic FKI-1778 and its production method |
| 02/13/2008 | CN101123990A Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| 02/13/2008 | CN101123973A 4000 to 10000 dalton oligodeoxyribonucleotides for treating tumor |
| 02/13/2008 | CN101123966A Combination therapy comprising the use of ET-743 and doxorubicin for treating cancer |
| 02/13/2008 | CN101123958A Combinational radiotherapy and chemotherapy compositions and methods |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121743A Process for extracting anticancer product from natural plant |
| 02/13/2008 | CN101121742A Panaxadiol fatty acid esters derivatives, preparation method and application thereof in pharmacy |
| 02/13/2008 | CN101121739A Hydrolysable tannin and application thereof |
| 02/13/2008 | CN101121738A 1,3-O-di-galloyl-6-O-(S)-decapetalous caesalpinia acyl-beta-D-glucopyranose and application thereof |
| 02/13/2008 | CN101121737A Novel hydrolysable tannin and application thereof |
| 02/13/2008 | CN101121711A Pyrazolcarbazone derivatives and application thereof |
| 02/13/2008 | CN101121706A Coumarin derivatives, preparation method and use thereof |
| 02/13/2008 | CN101121674A Compound N-((2R,3S,E)-1,3-dihydroxy-17-methyloctadecyl-8-en-2-yl)acetamide |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121019A Use of division deficient protein 3 |
| 02/13/2008 | CN101121010A Tumor-treating medicine |
| 02/13/2008 | CN101120977A Medicine for treating tumor |
| 02/13/2008 | CN101120970A Phenolic extract of duchesnea indica focke, preparation method and application thereof |
| 02/13/2008 | CN101120960A Total terpenes extraction extracted from stem of celastrus obiculatus and preparation method and application thereof |
| 02/13/2008 | CN101120959A Application of guhong injection for treating lung cancer |
| 02/13/2008 | CN101120958A Medicinal preparation for treating liver cancer and leukemia and producing technology thereof |
| 02/13/2008 | CN101120948A Compound composition with chemical protecting, cancer preventing and treating use |
| 02/13/2008 | CN101120945A Application of 8-arylamine-3H-imidazole [4, 5-g] quinazoline derivatives |
| 02/13/2008 | CN101120943A Medicinal composition for treating glioma, preparation method and preparation thereof |
| 02/13/2008 | CN101120941A Methylcantharidimide injection and freeze-dried powder injection for treating tumor and preparation method thereof |
| 02/13/2008 | CN101120940A Application of tanshinone IIA sodium sulfonate as blood-brain barrier protecting agent in cerebral diseases |
| 02/13/2008 | CN101120938A Application of chlorogenic acid in preparing medicine for treating small cell lung cancer |
| 02/13/2008 | CN101120937A Application of chlorogenic acid in preparing medicine with cervical cancer preventing and treating efficiency |
| 02/13/2008 | CN101120936A Application of chlorogenic acid in preparing medicine with estrogenic or estrogenic promoting action |
| 02/13/2008 | CN101120925A Freezing-dried clofarabine powder injection and its preparation method |
| 02/13/2008 | CN101120920A Tegafur enous emulsion and preparation method thereof |
| 02/13/2008 | CN101120919A Etoposide venous emulsion and preparation method thereof |
| 02/13/2008 | CN101120776A Method for extracting beta-glucan from cereal bran using membrane separation technology |
| 02/13/2008 | CN100368436C Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 02/13/2008 | CN100368435C Arf6 activator protein and its coding gene and application |
| 02/13/2008 | CN100368433C Bean-potato antitumour protein |
| 02/13/2008 | CN100368431C Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 02/13/2008 | CN100368430C Solasodine hydrofluoric acid salt and its preparation method and its uses in medicine |
| 02/13/2008 | CN100368429C Solasodine hydriodate and its preparation method and its uses in medicine |
| 02/13/2008 | CN100368428C 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 02/13/2008 | CN100368424C Tumor inhibiting antisense nucleotide |
| 02/13/2008 | CN100368423C Small interference RNA molecule (SiRNA) capable of effectively killing and wounding tumour cell pointed at PLK1 mRNA, its mixture and use |
| 02/13/2008 | CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/13/2008 | CN100368413C Composition stable blood porphrin derivative, its preparation method and injection agent |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368401C Cyanoguanidine prodrugs |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368373C Carboxyl substituted resveratrol analog compound and its preparation method |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100368018C Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100368013C Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 02/13/2008 | CN100367955C Compsn. of medication of containing creat lactone of triacetyl and usages |
| 02/13/2008 | CN100367953C Quercetin solid liposome nano particle preparation and its preparing method |
| 02/13/2008 | CN100367950C Anticancer diterpene analog compound intravenous injection formulation, and its preparation method and uses |
| 02/13/2008 | CN100367948C Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367944C Allicin microcapsule and its preparation method |
| 02/13/2008 | CN100367931C Method of drug loading in liposomes by gradient |
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/12/2008 | US7329760 CC-1065 analog synthesis |
| 02/12/2008 | US7329759 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; may also be targeted to a particular tumor; can either be cytostatic or cytotoxic to the tumor cells |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329734 Comprises recombinant insulin like growth factor receptor interacting protein for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329728 Ligand activated transcriptional regulator proteins |
| 02/12/2008 | US7329687 Anticancer agents; antiproliferative agents |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329666 Antitumor agents |
| 02/12/2008 | US7329663 Substituted-triazolopyrimidines as anticancer agents |
| 02/12/2008 | US7329661 N-phenyl-3-pyrimidine-amine derivatives |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329649 Combinatorial methods for inducing cancer cell death |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329541 Zinc finger binding domains for GNN |
| 02/12/2008 | US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329422 Treating breast or liver cancer with a concentrate formed by extracting rhizomes of Fagopyrum dibotrys (golden buckwheat) with alcohol and concentrating the extract to a powder or syrup, optionally followed by fractionation. |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2411577C Stabiliser for radiopharmaceuticals |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2385996C Anticancer agents |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |